- Home
- » Tags
- » CD40 (protein)
Top View
- The Cd40 Receptor Ð Target, Tool and Technology
- Targeted Disruption of Traf5 Gene Causes Defects in CD40- and CD27-Mediated Lymphocyte Activation
- Receptor Signaling Through Osteoclast-Associated Monocyte
- CD40 Antibodies, Mouse for Research Use Only
- The TNF Superfamily
- Act1, a Negative Regulator in CD40- and BAFF-Mediated B Cell Survival
- Apoptotic and Antitumor Activity of Death Receptor Antibodies Require Inhibitory Fcγ Receptor Engagement
- Development of Improved Soluble Inhibitors of Fasl and CD40L
- Of Human B Cells CD137 Promotes Proliferation and Survival
- A Novel Function of CD40: Induction of Cell Death in Transformed Cells by Sigrun Hess and Hartmut Engelmann
- CD30 Is a CD40-Inducible Molecule That Negatively Regulates CD40-Mediated Immunoglobulin Class Switching in Non-Antigen-Selected Human B Cells
- Prospects for CD40-Directed Experimental Therapy of Human
- Cell Protection from Fas-Mediated Apoptosis CD21/CD19/CD81 In
- CD40 Expression in Human Esophageal Squamous Cell
- A Novel Mechanism of CD40-Induced Apoptosis of Carcinoma Cells Involving TRAF3 and JNK/AP-1 Activation
- Quantification and Functional Evaluation of CD40L Production
- Expression of CD40 Correlates Negatively with Overall And
- CD40 Is Expressed on Ovarian Cancer Cells and Can Be Utilized for Targeting Adenoviruses1
- Latent Sensitivity to Fas-Mediated Apoptosis After CD40 Ligation May Explain Activity of CD154 Gene Therapy in Chronic Lymphocytic Leukemia
- Strong and Selective Glomerular Localization of CD134 Ligand and TNF Receptor-1 in Proliferative Lupus Nephritis
- Anticancer Immunity Induced by a Synthetic Tumor-Targeted CD137 Agonist
- Induction of Human Dendritic Cell Maturation by Naã¯Ve and Memory
- The Quantity of CD40 Signaling Determines the Differentiation of B
- Signaling Through JNK Cells Mediated by CD27 and CD40 Involves
- Overexpression of CCN1 in Het1a Cells Attenuates Bile-Induced Esophageal Metaplasia Through Suppressing Non-Canonical Nfκb Activation T
- CD40L Costimulatory Pathways − CD40
- CD137 As an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
- And CD40-Targeting Vaccination Promotes Human B Cell Maturation and Igg Induction Via Pdc-Dependent Mechanisms in Humanized Mice
- CD40-Directed Scfv-TRAIL Fusion Proteins Induce CD40-Restricted Tumor Cell Death and Activate Dendritic Cells
- Table Continues on Reverse Matrix Metalloproteinase-7 (MMP-7) P09237 Programmed Cell Death Protein 1 (PDCD1) Q15116
- The Role of Novel T Cell Costimulatory Pathways in Autoimmunity and Transplantation
- B Lymphocyte Activation by Contact-Mediated Interactions with T Lymphocytes Gail a Bishop* and Bruce S Hostager†
- Agonistic CD40 Antibodies in Cancer Treatment
- Activation of B Cells Using Schneider 2 Cells Expressing CD40 Ligand for the Enhancement of Antigen Presentation in Vitro
- CD154±CD40-Independent Up-Regulation of B7-2 on Splenic
- Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy Atsushi Yonezawa1,2, Suparna Dutt3, Cariad Chester1,4, Jeewon Kim5, and Holbrook E
- CD40 Expression by Human Peripheral Blood Eosinophils
- Improving Combination Cancer Immunotherapy with a Novel, Dual-Specific Immunotherapeutic Platform That Links T Cell Costimulatory Pathways
- The Roles of CD137 Signaling in Atherosclerosis
- Open Full Page
- A Costimulatory Function for T Cell CD40 Melissa E
- Mutational Screening of the CD40 Ligand (CD40L) Gene in Patients